Results 71 to 80 of about 5,671 (151)

Enteric Coating Enhances the Biopharmaceutical Performance of a Silica-Lipid Formulation of Abiraterone Acetate. [PDF]

open access: yesPharmaceutics
Taheri A   +6 more
europepmc   +1 more source

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer. [PDF]

open access: yesInvest New Drugs
Chandran K   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy